Skip to main content
The Making of Medicine

Tag: cancer (Page 4)

Researchers Lelisa F. Gemta (left) and Timothy Bullock have determined why killer T cells can be so helpless against cancer. Their discovery could help doctors make the immune cells much more effective against cancer.
Making Immune Cells Better Cancer Killers

Our Timothy Bullock, PhD, and his team have discovered a defect in immune cells known as “killer T cells” that explains why they struggle to destroy cancer tumors. By fixing this defect, scientists could make the cells much better at killing cancer cells.

Anindya Duttta, PhD, holds his hands open wide while standing in a white lab coat in his lab.
HPV Discovery Opens Door to New Cancer Treatments

Anindya Dutta and his colleagues have identified a substance that is essential for the sexually transmitted virus to cause cancer. That discovery could lead to new treatments for HPV cancers.

Shayna Showalter, MD, a breast cancer surgeon, and her husband, Tim Showalter, MD, a radiation oncologist, stand in front of a large machine.
A Husband and Wife Working to Improve Breast Cancer Care

Tim and Shayna Showalter, who are married, have developed a technique called Precision Breast Intraoperative Radiation, which aims to improve on conventional breast IORT by making it more targeted, more powerful, more personalized and, hopefully, more effective.

One of 2017’s Top 10 Clinical Research Achievements!

Here's a well-earned recognition: Our Daniel "Trey" Lee's pioneering work in battling pediatric leukemia has been honored as one of 2017’s top 10 Clinical Research Achievements by the Clinical Research Forum. Dr. Lee’s research weaponizes immune cells, known as T cells, in pediatric and young adult clinical trial participants to…

Anindya Dutta, PhD, is the chairman of the UVA Department of Biochemistry and Molecular Genetics.
How Our Cells Repair Damaged DNA

Our Anindya Dutta, MD, PhD, has made an important discovery suggesting that 10 percent to 15 percent of prostate cancer and lymphomas have a genetic weakness that makes them particularly vulnerable to chemotherapy and radiation therapy. That should be very good news for patients with that subset of cancers. But…